<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083026</url>
  </required_header>
  <id_info>
    <org_study_id>KNUCH-2021005-001-001</org_study_id>
    <nct_id>NCT05083026</nct_id>
  </id_info>
  <brief_title>Neutralizing Antibody Level After COVID-19 Vaccination</brief_title>
  <official_title>Neutralizing Antibody Level After COVID-19 Vaccination in Hospital Works.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyungpook National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyungpook National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. serial of neutralizing antibody at 2, 4, 6, 9, 12 month after COVID-19 vaccination&#xD;
&#xD;
        2. investigate the factors on antibody titer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. serial of neutralizing antibody at 2, 4, 6, 9, 12 month after COVID-19 vaccination 1)&#xD;
           semi-quantitative measurement of neutralizing antibody at 2, 4, 6, 9, 12 month after&#xD;
           COVID-19 vaccination 2) investigate the duration maintaining acceptable range (over 30%&#xD;
           inhibition)&#xD;
&#xD;
        2. investigate the factors on antibody titer at 2 month after vaccination 1) potential&#xD;
           factors: age, sex, body weight, height, use of medication, use of antipyretics (NSAID or&#xD;
           tyrenol), side effect of COVID-19 vaccination 2) correlation between antibody titer and&#xD;
           potential factors&#xD;
&#xD;
        3. Compare 4 diagnostic ELISA kit at 2 month after vaccination 1) measure neutralizung&#xD;
           antibody using ELISA kits from 4 different companies 2) investigate correlation&#xD;
           coefficient of antibody titer between companies&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>titer of neutralizing antibody after COVID-19 vaccination</measure>
    <time_frame>at 2month after COVID-19 vaccination</time_frame>
    <description>semi-quantitative measurement of neutralizing antibody after COVID-19 vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>titer of neutralizing antibody after COVID-19 vaccination</measure>
    <time_frame>at 4 month after COVID-19 vaccination</time_frame>
    <description>semi-quantitative measurement of neutralizing antibody after COVID-19 vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>titer of neutralizing antibody after COVID-19 vaccination</measure>
    <time_frame>at 6 month after COVID-19 vaccination</time_frame>
    <description>semi-quantitative measurement of neutralizing antibody after COVID-19 vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>titer of neutralizing antibody after COVID-19 vaccination</measure>
    <time_frame>at 9 month after COVID-19 vaccination</time_frame>
    <description>semi-quantitative measurement of neutralizing antibody after COVID-19 vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>titer of neutralizing antibody after COVID-19 vaccination</measure>
    <time_frame>at 12 month after COVID-19 vaccination</time_frame>
    <description>semi-quantitative measurement of neutralizing antibody after COVID-19 vaccination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>body weight (Kg)</measure>
    <time_frame>at 2 month after COVID-19 vaccination</time_frame>
    <description>correlation between antibody titer and body weight: spearmann's correlation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>body mass index (kg/m^2)</measure>
    <time_frame>at 2 month after COVID-19 vaccination</time_frame>
    <description>correlation between antibody titer and body weight: spearmann's correlation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare 4 diagnostic ELISA kit after COVID-19 vaccination</measure>
    <time_frame>at 2 month after COVID-19 vaccination</time_frame>
    <description>measure neutralizung antibody using ELISA kits from 4 different companies 2 months after COVID-19 vaccination&#xD;
investigate correlation coefficient of antibody titer between companies</description>
  </primary_outcome>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>COVID-19 neutralizing antibody</intervention_name>
    <description>This study enrolled persons already who received COVID-19 vaccination under government policy.&#xD;
We collect 5mL blood at 2, 4, 6, 9, 12 months after COVID-19 vaccination&#xD;
isolate serum and store in -80 degree deep freezer&#xD;
measure neutralizing Antibody</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      1. 5mL blood at 2, 4, 6, 9, 12 months after COVID-19 vaccination.&#xD;
&#xD;
        2. centrifuge and get serum sample&#xD;
&#xD;
        3. store at -80 degree deep freezer until use&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        healthcare works aged 20-60 years after completion of COVID-19 vaccination&#xD;
&#xD;
        participants have no serious disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthcare works after completion of COVID-19 vaccination&#xD;
&#xD;
          -  20-60 years&#xD;
&#xD;
          -  sign the agreement of study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  serious underlying diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Su Youn Nam, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Su Youn Nam, MD, PhD</last_name>
    <phone>82-53-200-2610</phone>
    <email>nam20131114@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kyungpook National University Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>41404</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Su Youn Nam, MD, PhD</last_name>
      <phone>82-53-200-2610</phone>
      <email>nam20131114@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 8, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyungpook National University Hospital</investigator_affiliation>
    <investigator_full_name>Su Youn Nam</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Antibodies, Blocking</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

